Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In an earlier report we showed that the 5' end of the gene for
ataxia telangiectasia
ATM
is within 700 bp of the 5' end of a novel gene E14, and suggested that the CpG island that separates these genes functions as a bidirectional promoter. We have now determined the complete amino acid sequence of the
E14 protein
, defined the exon/intron structure of the gene and estimate that the complete gene is more than 55 kb in length. The E14 gene appears to be a housekeeping gene that is expressed in all tissues, including all parts of the brain. The E14/
ATM
promoter organisation is conserved in man, monkey and mouse, although the mouse promoter is more compact and appears to lack two of the four putative Sp1 boxes found in the human promoter. Reporter gene constructs showed that the human and mouse E14/
ATM
promoters were indeed bidirectional, that the
ATM
side of the human promoter was three times stronger than the E14 side, and that the mouse promoter (in human cells) directed transcription with equal efficiency in both directions, but at a lower level than the human promoter. Analysis of a small number of A-T patients for mutations in the promoter region or the E14 coding sequence did not provide evidence to suggest that E14 contributes to the A-T phenotype.
...
PMID:A gene transcribed from the bidirectional ATM promoter coding for a serine rich protein: amino acid sequence, structure and expression studies. 892 7
Ataxia-telangiectasia
(
A-T
) is an autosomal recessive disorder involving cerebellar degeneration, immunodeficiency, chromosomal instability, radiosensitivity, and cancer predisposition. The genomic organization of the
A-T
gene, designated
ATM
, was established recently. To date, more than 100
A-T
-associated mutations have been reported in the
ATM
gene that do not support the existence of one or several mutational hotspots. To allow genotype/phenotype correlations it will be important to find additional
ATM
mutations. The nature and location of the mutations will also provide insights into the molecular processes that underly the disease. To facilitate the search for
ATM
mutations and to establish the basis for the identification of transcriptional regulatory elements, we have sequenced and report here 184,490 bp of genomic sequence from the human 11q22-23 chromosomal region containing the entire
ATM
gene, spanning 146 kb, and 10 kb of the 5'-region of an adjacent gene named
E14/NPAT
. The latter shares a bidirectional promoter with
ATM
and is transcribed in the opposite direction. The entire region is transcribed to approximately 85% and translated to 5%. Genome-wide repeats were found to constitute 37.2%, with LINE (17.1%) and Alu (14.6%) being the main repetitive elements. The high representation of LINE repeats is attributable to the presence of three full-length LINE-1s, inserted in the same orientation in introns 18 and 63 as well as downstream of the
ATM
gene. Homology searches suggest that
ATM
exon 2 could have derived from a mammalian interspersed repeat (MIR). Promoter recognition algorithms identified divergent promoter elements within the CpG island, which lies between the
ATM
and
E14/NPAT
genes, and provide evidence for a putative second
ATM
promoter located within intron 3, immediately upstream of the first coding exon. The low G+C level (38.1%) of the
ATM
locus is reflected in a strongly biased codon and amino acid usage of the gene.
...
PMID:Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. 919 32